You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

androgen independent prostate cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

Recruiting
  • Prostate Cancer
  • Prostate Disease
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 11, 2022

Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • triptorelin, goserelin, leuprorelin
  • (no location specified)
Mar 10, 2023

Prostate Cancer, Biochemical Recurrence Trial in Nanjing (Rezvilutamide, Androgen deprivation therapy (ADT), SRT)

Recruiting
  • Prostate Cancer
  • Biochemical Recurrence
  • Nanjing, Jiangsu, China
  • +1 more
Mar 2, 2023

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2023

Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)

Recruiting
  • Prostate Cancer
  • Brasília, Distrito Federal, Brazil
  • +4 more
Dec 22, 2022

Physical Function During ARSI Treatment

Recruiting
  • Advanced Prostate Carcinoma
  • androgen receptor signaling inhibitors
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 8, 2022

Prostate Cancer Trial in Ann Arbor, Seattle (Aplidin (plitidepsin))

Terminated
Has Results
  • Prostate Cancer
  • Aplidin (plitidepsin)
  • Ann Arbor, Michigan
  • +1 more
Nov 16, 2020

Prostate Cancer Trial in Madison (radiation, drug, diagnostic test)

Not yet recruiting
  • Prostate Cancer
  • External beam radiation therapy
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin
Jul 25, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Prostate Cancer Trial in Atlanta, Charleston (Opaganib, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Atlanta, Georgia
  • +1 more
Dec 28, 2022

Based Discrete Choice Experiment Study in Prostate Cancer Study

Completed
  • Prostate Cancer
  • Metastatic Hormone-sensitive Prostate Cancer
    • Durham, North Carolina
      Duke Clinical Research Institute
    Jan 10, 2023

    Strength, Aging, and Memory in Prostate Cancer

    Active, not recruiting
    • Prostate Neoplasm
    • Prostate Cancer
    • Androgen deprivation therapy
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Jul 13, 2022

    Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

    Not yet recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • (no location specified)
    Feb 2, 2023

    Prostatic Tumors Trial (Prostate SBRT with Focal Boost, Triptorelin Injection)

    Not yet recruiting
    • Prostatic Neoplasms
    • Prostate SBRT with Focal Boost
    • Triptorelin Injection
    • (no location specified)
    May 1, 2023

    Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))

    Not yet recruiting
    • Metastatic Castrate-sensitive Prostate Cancer
    • Lakewood, Colorado
    • +5 more
    May 23, 2023

    High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

    Not yet recruiting
    • High-Risk Prostate Cancer
    • Portland, Oregon
      VA Portland Health Care System, Portland, OR
    Jan 17, 2023

    Prostate Cancer Trial (iMAB, cMAB)

    Not yet recruiting
    • Prostate Cancer
    • (no location specified)
    Jul 26, 2023

    Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))

    Recruiting
    • Cancer Of Prostate
    • M9241
    • Stereotactic Body Radiation Therapy (SBRT)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML

    Recruiting
    • Castration-resistant Prostate Cancer
    • Homologous Recombination Deficiency
    • Testosterone Enanthate 100 MG/ML Injectable Solution
    • Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
    • Sydney, New South Wales, Australia
      Kinghorn Cancer Centre, St. Vincent's Hospital
    Dec 16, 2022

    Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

    Active, not recruiting
    • Prostate Adenocarcinoma
    • +5 more
    • Androgen Suppression
    • +3 more
    • Scottsdale, Arizona
    • +1 more
    Jan 5, 2023

    Recurrent Prostate Cancer Trial in Salisbury, Winston-Salem (MGE, Placebo, ADT)

    Recruiting
    • Recurrent Prostate Cancer
    • Salisbury, North Carolina
    • +1 more
    Nov 2, 2022

    Learn More About How Safe Darolutamide is Under Real-world

    Not yet recruiting
    • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
    • No Intervention
    • Multiple Locations, Japan
      Many Locations
    Aug 24, 2023

    Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)

    Completed
    Has Results
    • Prostate Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 23, 2022

    Androgen Deprivation Therapy, Locally Advanced Prostate Cancer Trial in Oklahoma City (Relugolix and Enzalutamide)

    Not yet recruiting
    • Androgen Deprivation Therapy
    • Locally Advanced Prostate Cancer
    • Relugolix and Enzalutamide
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center at OU Health, University of Oklahoma He
    Nov 8, 2023